Tipih, Thomas
Leventhal, Shanna S.
Meade-White, Kimberly
Lewis, Matthew
Bushmaker, Trenton
Shaia, Carl
Marzi, Andrea
Feldmann, Heinz
Hawman, David W.
Funding for this research was provided by:
Intramural Research Program of NIAID, NIH
Article History
Received: 7 January 2025
Accepted: 12 May 2025
First Online: 30 May 2025
Competing interests
: H.F. claims intellectual property of VSV-based filovirus vaccines. All other authors declare no competing interests.